Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer ; volume:9 ; number:1 ; day:13 ; month:8 ; year:2009 ; pages:1-9 ; date:12.2009
BMC cancer ; 9, Heft 1 (13.8.2009), 1-9, 12.2009
- Urheber
-
Mlakar, Vid
- Beteiligte Personen und Organisationen
-
Berginc, Gašper
Volavšek, Metka
Štor, Zdravko
Rems, Miran
Glavač, Damjan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-282
- URN
-
urn:nbn:de:1111-2016030352385
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.0001, 06:37 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mlakar, Vid
- Berginc, Gašper
- Volavšek, Metka
- Štor, Zdravko
- Rems, Miran
- Glavač, Damjan
- SpringerLink (Online service)
Ähnliche Objekte (12)
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Regulation of the NF2 tumour suppressor Merlin
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Computational identification of tumour suppressor protein p53 target genes
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
The tumour suppressor p53 as a supporter of DNA replication
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Regulation of the NF2 tumour suppressor Merlin
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Computational identification of tumour suppressor protein p53 target genes
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
The tumour suppressor p53 as a supporter of DNA replication
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Regulation of the NF2 tumour suppressor Merlin
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Computational identification of tumour suppressor protein p53 target genes
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
The tumour suppressor p53 as a supporter of DNA replication
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q